These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32220141)
1. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Greenland NY; Cowan JE; Zhang L; Carroll PR; Chan E; Stohr BA; Simko JP Prostate; 2020 May; 80(8):653-659. PubMed ID: 32220141 [TBL] [Abstract][Full Text] [Related]
2. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Greenland NY; Cooperberg MR; Wong AC; Chan E; Carroll PR; Simko JP; Stohr BA Investig Clin Urol; 2022 Jan; 63(1):27-33. PubMed ID: 34983120 [TBL] [Abstract][Full Text] [Related]
3. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer. Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432 [TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Chappidi MR; Sjöström M; Greenland NY; Cowan JE; Baskin AS; Shee K; Simko JP; Chan E; Stohr BA; Washington SL; Nguyen HG; Quigley DA; Davicioni E; Feng FY; Carroll PR; Cooperberg MR Eur Urol Oncol; 2024 Apr; 7(2):222-230. PubMed ID: 37474400 [TBL] [Abstract][Full Text] [Related]
5. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification. Greenland NY; Cooperberg MR; Carroll PR; Cowan JE; Simko JP; Stohr BA; Chan E Prostate; 2024 Aug; 84(11):1076-1085. PubMed ID: 38734990 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease. Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy. Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4. Chen Z; Pham H; Abreu A; Amin MB; Sherrod AE; Xiao GQ; Aron M Hum Pathol; 2021 Dec; 118():18-29. PubMed ID: 34543668 [TBL] [Abstract][Full Text] [Related]
9. Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort. Haffner MC; Salles DC; Gao G; Epstein JI Hum Pathol; 2020 Apr; 98():74-80. PubMed ID: 32119879 [TBL] [Abstract][Full Text] [Related]
10. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential. Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374 [TBL] [Abstract][Full Text] [Related]
11. [SIGNIFICANCE OF INTRADUCTAL CARCINOMA OF THE PROSTATE IN POST-OPERATIVE BIOCHEMICAL RECURRENCE]. Sakamoto N; Ueda S; Mizoguchi H; Kawahara I; Kobayashi T; Hamaguchi M; Yoshikawa M Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):5-11. PubMed ID: 29367511 [TBL] [Abstract][Full Text] [Related]
12. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients. Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Roobol MJ; van Leenders GJLH Mod Pathol; 2021 Jan; 34(1):184-193. PubMed ID: 32686748 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer. Flood TA; Schieda N; Sim J; Breau RH; Morash C; Belanger EC; Robertson SJ Virchows Arch; 2018 Feb; 472(2):205-212. PubMed ID: 28975495 [TBL] [Abstract][Full Text] [Related]
14. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease. Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782 [TBL] [Abstract][Full Text] [Related]
15. Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier. Taylor AS; Morgan TM; Wallington DG; Chinnaiyan AM; Spratt DE; Mehra R Prostate; 2020 Feb; 80(2):146-152. PubMed ID: 31737920 [TBL] [Abstract][Full Text] [Related]
16. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification. Rehman A; El-Zaatari ZM; Han SH; Shen SS; Ayala AG; Miles B; Divatia MK; Ketcham MS; Chung BM; Rogers JT; Ro JY Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915 [TBL] [Abstract][Full Text] [Related]
17. Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy. Shimodaira K; Inoue R; Hashimoto T; Satake N; Shishido T; Namiki K; Harada K; Nagao T; Ohno Y Cancer Med; 2024 Mar; 13(5):e7086. PubMed ID: 38477506 [TBL] [Abstract][Full Text] [Related]
18. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027 [TBL] [Abstract][Full Text] [Related]
19. Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer. Sved PD; Gomez P; Manoharan M; Kim SS; Soloway MS J Urol; 2004 Jul; 172(1):98-102. PubMed ID: 15201746 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions. Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]